Rankings
▼
Calendar
PHIO FY 2017 Earnings — Phio Pharmaceuticals Corp. Revenue & Financial Results | Market Cap Arena
PHIO
Phio Pharmaceuticals Corp.
$13M
FY 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$15,000
-21.1% YoY
Gross Profit
-$5M
-35700.0% margin
Operating Income
-$14M
-93746.7% margin
Net Income
-$12M
-83013.3% margin
EPS (Diluted)
$-32801.22
Cash Flow
Operating Cash Flow
-$10M
Free Cash Flow
-$10M
Stock-Based Comp.
$314,000
Balance Sheet
Total Assets
$4M
Total Liabilities
$2M
Stockholders' Equity
$2M
Cash & Equivalents
$4M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$15,000
$19,000
-21.1%
Gross Profit
-$5M
-$5M
+0.8%
Operating Income
-$14M
-$9M
-56.0%
Net Income
-$12M
-$9M
-38.4%
← Q4 2016
All Quarters
Q1 2017 →